Login | Register

Adcetris (Brentuximab Vedotin) Gets Conditional European Marketing Authorization

Adcetris (Brentuximab Vedotin) has been approved in the European Union for patients with certain types of lymphoma, Millennium announced today...

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *